IKMG Research Group - 4th International Meeting


IKMG 4th Meeting - PROGRAM.pdf


IKMG 4th Meeting - ABSTRACTS.pdf

Thursday May 23 2019
7:00 am:    Registration and Breakfast

8:00 am:    Opening remarks

8:15 am:    MGRS-related kidney diseases
               1. The updated classification of MGRS-related kidney diseases: Nelson Leung

                                2. State of the art of the techniques for the diagnosis of M-Ig related kidney diseases: Vivette D’Agati

9:15 am:    Proliferative Glomerulonephritis with non-organized monoclonal immunoglobulin deposits (PGNMID)
              1. Pathology of PGNMID: Samih Nasr
                               2. Clinical and hematological characteristics of PGNMID: Jonathan Hogan            

                                3. Update on treatment of PGNMID: Nelson Leung

10:45 am:  Break

11:00 am:  Light Chain Cast Nephropathy
            1. Pathology of light chain cast nephropathy: Virginie Royal
                               2. Current criteria for renal response in light chain cast nephropathy: Efstathios Kastritis
                               3. Treatment of light chain cast nephropathy/MYRE study: Frank Bridoux 

12:30 pm:  Lunch

2:00 pm:    Biological and diagnosis
             1. Update on monoclonal protein detection/measurement: Mass spectrometry: David Murray
                             2. Proteomics in the diagnosis of M-Ig related kidney diseases: Surendra Dasari
Immunoglobulin Repertoire Sequencing (RepSeq): A new tool for diagnosis and treatment
                                  follow-up in monoclonal gammopathy of clinical significance
: Christophe Sirac

3:30 pm:    Break

4:00 pm:    Oral Communications

                             1. Free light chain-induced proximal tubule injury is mediated via toll-like receptors 2/4 through generation of HMGB1: Vecihi                                            Batuman

                             2. Monoclonal gammopathies and their significance: A retrospective analysis of monoclonal gammopathy and renal disease: Cindy                                   Varga

                              3. Light chain deposition disease (LCDD) and renal light chain (AL) amyloidosis: different clinical presentation and renal outcome:                                         Paolo Milani

                              4. Management of first relapse non IgM light chain amyloidosis: a french multicentric retrospective study: Camille Villesuzanne

                              5. Histologic and Molecular Correlates in Patients with AL Amyloidosis in Remission But With Persistent Renal Disease: Cindy Varga

                              6. Renal histopathology spectrum of Monoclonal Gammopathy of Renal Significance : A single referral lab experience: Rajan Duggal

                              7. Contribution in the understanding of Heavy Chain Deposition Disease molecular mechanisms: Sébastien Bender

                              8. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) : a case series of 71 patients: Vincent                                               Javaugue

                              9. Diagnostic Pathway in Patients Presenting with Acute Kidney Injury Secondary to de novo Multiple Myeloma: A Two Centre                                               Experience: Ritika Rana

                            10. Abnormal monoclonal immunoglobulins in plasma cell proliferations: a new animal model to study their role in plasma cell survival:                                     Maria Victoria Ayala

6:00 pm:    Reception and Posters

8:00 pm:    Dinner



Friday May 24 2019

7:00 am:     Breakfast

8:00 am:     Basic Science
Make it count: technical considerations and initial findings for accurate quantitative comparisons
                                   of urinary extracellular vesicles to determine minimal residual kidney disease in AL amyloidosis
: Marina Ramirez Alvarado

                               2. Understanding mesangial damage and repair in light-chain associated mesangiopathy: Guillermo Herrera

                               3. C3 glomerulopathy, thrombotic microangiopathy and monoclonal immunoglobulin: Sophie Chauvet
                               4. Pathophysiology of light chain cast nephropathy: Paul Sanders

10:30 am:   Break

10:45 am:   AL Amyloidosis
1. Pitfalls in the diagnosis of AL amyloidosis:  Ashutosh Wechalekar

                               2. Update on the treatments of AL amyloidosis: Arnaud Jaccard

                               3. Organ transplantation in Amyloidosis:  Andrea Havasi

12:30 pm:   Lunch

2:00 pm:     The Future

                             1. Overview of the novel treatments in Multiple Myeloma: Christopher Venner

                               2. Monoclonal Gammopathy of Clinical Significance: Jean-Paul Fermand

3:15 pm:     IKMG future directions and closing remarks

3:45 pm:     Break

4-6:00 pm:  Board meeting



This program is made possible through unrestricted grants from:







as well as a contribution of TOURISME MONTREAL